Depomed prevails in Gralise® ANDA litigation blocking generic entry until 2024
Depomed announced Judge Joel A. Pisano of the U.S. District Court for the District of New Jersey has ruled in favor of Depomed in the company's patent litigation lawsuit against Actavis related to Actavis's aNDA for generic versions of Depomed's Gralise® (gabapentin) tablets. August 19, 2014